drugset / Trial / NCT01327911
Ciliary Neurotrophic Factor (CNTF) Safety Trial in Patients With Macular Telangiectasia (Mactel)
Phase 1
Completed
7 enrolled
Neurotech Pharmaceuticals
The Lowy Medical Research Institute Limited · collab
NaSingle-groupOpen-labelTreatment
Summary
This study is a phase 1, open label, non-randomized, multi-center, pilot study to evaluate the safety and tolerability of NT-501 implants in 5-7 study participants with Mactel.
Timeline
- Start
- 2011-05
- Primary completion
- 2016-09
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ciliary neurotrophic factor | Cell therapy | — | — |